Log in

Relevant bibliographies by topics / Leukemia / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Leukemia.

Dissertations / Theses on the topic 'Leukemia'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Leukemia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Cheung, Man-sze, and 張敏思. "Characterization of Leukemic stem cells in acute myeloid Leukemia." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40687582.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cheung, Man-sze. "Characterization of Leukemic stem cells in acute myeloid Leukemia." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B40687582.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cornforth, Terri Victoria. "Characterising the cell biology of leukemic stem cells in acute myeloid leukemia." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:654b2176-fd50-427e-86f2-74e928054bef.

Full text

Abstract:

Acute Myeloid leukemia (AML) is an aggressive haematological malignancy that mainly affects the elderly. Relapse is common and is thought to be due to the presence of chemotherapy resistant leukemic stem cells (LSC). Within the CD34+ disease (>5% of the blast cells expressing CD34) , two subtypes have been identified; an LMPP/GMPlike expanded type and a MPP/CMP-like expanded type, the former is the most common, accounting for around 80% of CD34+ AML. Both the GMP-like and LMPPlike expanded populations show LSC activity. To improve our understanding of the disease and gain better insight in to

APA, Harvard, Vancouver, ISO, and other styles

4

Dutta, Sayantanee. "CALM/AF10 leukemia." Diss., Ludwig-Maximilians-Universität München, 2014. http://nbn-resolving.de/urn:nbn:de:bvb:19-174268.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bagacean, Cristina. "Epigenetics in leukemia." Thesis, Brest, 2018. http://www.theses.fr/2018BRES0012.

Full text

Abstract:

Les dérivés de la cytosine sont d’importantes modifications épigénétiques dont le rôle dans l’évolution de la leucémie lymphoïde chronique (LLC) n’est pas totalement exploré. Dans ce contexte, notre première étude vise à examiner le niveau global de la 5-methylcytosine (5-mCyt), 5-hydroxymethylcytosine (5-hmCyt), 5-carboxylcytosine (5-CaCyt) et 5-hydroxymethyluridine (5-hmU) dans des lymphocytes B purifiés de patients LLC (n=56) et d’individus sains (n=17). Les principaux acteurs de la régulation épigénétique (DNMT1/3A/3B, MBD2/4, TET1/2/3, SAT1) ont été évalués par PCR quantitative en temps r

APA, Harvard, Vancouver, ISO, and other styles

6

Papayannidis, Cristina <1980&gt. "Pre-clinical and clinical development of leukemia stem cell inhibitors in acute leukemias." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2013. http://amsdottorato.unibo.it/5596/1/TesiPapayannidisDottorato2013_Copy.pdf.

Full text

Abstract:

In Leukemias, recent developments have demonstrated that the Hedgehog pathway plays a key-role in the peculiar ability of self renewal of leukemia stem cells. The aim of this research activity was to investigate, through a first in man, Phase I, open label, clinical trial, the role and the impact, mainly in terms of safety profile, adverse events and pharmacokinetics, of a Sonic Hedgehog inhibitor compound on a population of heavely pretreated patients affected by AML, CML, MF, or MDS, resistant or refractory to standard chemotherapy. Thirty-five patients have been enrolled. The drug was admin

APA, Harvard, Vancouver, ISO, and other styles

7

Papayannidis, Cristina <1980&gt. "Pre-clinical and clinical development of leukemia stem cell inhibitors in acute leukemias." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2013. http://amsdottorato.unibo.it/5596/.

Full text

Abstract:

In Leukemias, recent developments have demonstrated that the Hedgehog pathway plays a key-role in the peculiar ability of self renewal of leukemia stem cells. The aim of this research activity was to investigate, through a first in man, Phase I, open label, clinical trial, the role and the impact, mainly in terms of safety profile, adverse events and pharmacokinetics, of a Sonic Hedgehog inhibitor compound on a population of heavely pretreated patients affected by AML, CML, MF, or MDS, resistant or refractory to standard chemotherapy. Thirty-five patients have been enrolled. The drug was admin

APA, Harvard, Vancouver, ISO, and other styles

8

Zhang, Lu [Verfasser]. "Immunogenicity of leukemia stem cells in acute myeloid leukemia / Lu Zhang." Ulm : Universität Ulm. Medizinische Fakultät, 2012. http://d-nb.info/1020022574/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Xue, Liting. "Oncogene Function in Pre-Leukemia Stage of INV(16) Acute Myeloid Leukemia: A Dissertation." eScholarship@UMMS, 2014. https://escholarship.umassmed.edu/gsbs_diss/740.

Full text

Abstract:

The CBFbeta-SMMHC fusion protein is expressed in acute myeloid leukemia (AML) samples with the chromosome inversion inv(16)(p13;q22). This fusion protein binds the transcription factor RUNX with higher affinity than its physiological partner CBFbeta and disrupts the core binding factor (CBF) activity in hematopoietic stem and progenitor cells. Studies in the Castilla laboratory have shown that CBFbeta-SMMHC expression blocks differentiation of hematopoietic progenitors, creating a pre-leukemic progenitor that progresses to AML in cooperation with other mutations. However, the combined function

APA, Harvard, Vancouver, ISO, and other styles

10

Xue, Liting. "Oncogene Function in Pre-Leukemia Stage of INV(16) Acute Myeloid Leukemia: A Dissertation." eScholarship@UMMS, 2010. http://escholarship.umassmed.edu/gsbs_diss/740.

Full text

Abstract:

The CBFbeta-SMMHC fusion protein is expressed in acute myeloid leukemia (AML) samples with the chromosome inversion inv(16)(p13;q22). This fusion protein binds the transcription factor RUNX with higher affinity than its physiological partner CBFbeta and disrupts the core binding factor (CBF) activity in hematopoietic stem and progenitor cells. Studies in the Castilla laboratory have shown that CBFbeta-SMMHC expression blocks differentiation of hematopoietic progenitors, creating a pre-leukemic progenitor that progresses to AML in cooperation with other mutations. However, the combined function

APA, Harvard, Vancouver, ISO, and other styles

11

Osuji, Nnenna. "Leukemias of Mature T-Cell Phenotype with Gene Expression Profiling in T-Cell prolymphocytic Leukemia." Thesis, Institute of Cancer Research (University Of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.498887.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Peng, Cong. "Novel Therapeutic Targets for Ph+ Chromosome Leukemia and Its Leukemia Stem Cells: A Dissertation." eScholarship@UMMS, 2010. https://escholarship.umassmed.edu/gsbs_diss/473.

Full text

Abstract:

The human Philadelphia chromosome (Ph) arises from a translocation between chromosomes 9 and 22 [t(9;22)(q34;q11)]. The resulting chimeric BCR-ABLoncogene encodes a constitutively activated, oncogenic tyrosine kinase that induces chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL). The BCR-ABL tyrosine kinase inhibitor (TKI), imatinib mesylate, induces a complete hematologic and cytogenetic response in the majority of CML patients, but is unable to completely eradicate BCR-ABL–expressing leukemic cells, suggesting that leukemia stem cells are not eliminated. Over tim

APA, Harvard, Vancouver, ISO, and other styles

13

Yaseen, Mumtaz. "Proteomics of Acute Myeloid Leukemia:." Diss., lmu, 2007. http://nbn-resolving.de/urn:nbn:de:bvb:19-69882.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Gunnarsson, Niklas. "Chronic myeloid leukemia and cancer." Doctoral thesis, Umeå universitet, Medicin, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-141144.

Full text

Abstract:

Background Chronic myeloid leukemia (CML) is a relatively rare hematological malignancy with a constant incidence of approximately 90 new cases each year in Sweden (0.9 cases/100 000 inhabitants). The etiology is largely unknown but high doses of ionizing radiation are a known but rare risk factor. The treatment options were for a long time limited to chemotherapies i.e. hydroxyurea and busulfan, interferon’s and allogeneic hematopoietic stem cell transplantation and the median survival were only about four years. Since the beginning of the 21st century a new way of treating CML has been intr

APA, Harvard, Vancouver, ISO, and other styles

15

Hammarsund, Marianne. "Genetic changes in lymphoid leukemia /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-628-5841-6/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

PIKE, SARAH-ANN KATHLEEN. "TREATMENT RELATED COMPLICATIONS IN LEUKEMIA." Thesis, The University of Arizona, 2008. http://hdl.handle.net/10150/192203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Paganin, Maddalena. ""High Risk" Acute Lymphoblastic Leukemia." Doctoral thesis, Università degli studi di Padova, 2009. http://hdl.handle.net/11577/3427207.

Full text

Abstract:

Acute lymphoblastic leukemia (ALL) is a neoplasia characterized by an abnormal, clonal and self-maintaining proliferation of lymphoid cells. In this three year of phd I tried to add some information to understand the complex molecular mechanisms underlying this disease. I performed my studies in the laboratory of "Oncoematologia Pediatrica, Dipartimento di Pediatria dell'Università degli studi di Padova" and for three months in the laboratory of Prof. A. A. Ferrando, Columbia University, Irving Cancer Center, New York. The recombination, insertion and deletion of immunoglobulin (Ig) and T

APA, Harvard, Vancouver, ISO, and other styles

18

Kuchinskaya, Ekaterina. "Genetic studies of acute lymphoblastic leukemia /." Stockholm : Karolinska institutet, 2007. http://diss.kib.ki.se/2007/978-91-7357-337-5/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Thörn, Ingrid. "Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-101028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Logan, Patricia Marie. "Detection and possible significance of a common leukemia-associated antigen, CAMAL, in human myeloid leukemia." Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/28860.

Full text

Abstract:

Human acute nonlymphoblastic or myelogenous leukemia (ANLL or AML) is a malignant disease of the bone marrow involving hemopoietic (blood-forming) cells of the myeloid lineage. ANLL is a complex neoplastic disease, whose fundamental nature is only partially understood despite intensive research. The disease is complicated by its apparent heterogeneity in terms of the degree of differentiation of hemopoietic stem cell involvement in different patients and the cellular expression of immunologically defined surface markers. The presence of a common antigen in myelogenous leukemia (CAMAL) has been

APA, Harvard, Vancouver, ISO, and other styles

21

Ihme, Erika Ruth Susann [Verfasser]. "Characterization of the Leukemia Initiating Cell in Human Acute Myeloid Leukemia / Erika Ruth Susann Ihme." Ulm : Universität Ulm, 2016. http://d-nb.info/1126036323/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Deshpande, Aniruddha. "Characterisation of the Leukemic Stem Cell in a Murine Model of CALM/AF10 Positive Myeloid Leukemia." Diss., lmu, 2006. http://nbn-resolving.de/urn:nbn:de:bvb:19-57555.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Morisot, Sebastien. "Détermination of the frequency of leukemia stem cells in childhood precursor B cell acute lymphoblastic leukemias." Paris 11, 2009. http://www.theses.fr/2009PA11T022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Naumburg, Estelle. "Perinatal Risk Factors for Childhood Leukemia." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2002. http://publications.uu.se/theses/91-554-5205-1/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Voyle, Roger Bruce. "Mechanisms of intracellular and extracellular cytokine production from the human leukaemia inhibitory factor gene." Title page, contents and summary only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phv975.pdf.

Full text

Abstract:

Addendum attached to back facing leaves. Includes bibliographical references (leaves 172-199). The findings establish leukemia inhibitory factor, and possibly oncostatin M, as new members of a small but growing class of cytokines produced in an intracellularly active form and also suggest that the production of alternate transcripts and intercellularly-retained proteins may be a common and important feature of cytokines of the IL-6 and other families.

APA, Harvard, Vancouver, ISO, and other styles

26

Kwok, Suet-kei Gladys. "The effectiveness of a chemotherapy educational programme (CEP) for Leukaemia and Lymphoma patients." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31972937.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

McLellan, Gail. "The role of monoclonal antibodies in the diagnosis of acute leukaemia." Thesis, Cape Technikon, 1990. http://hdl.handle.net/20.500.11838/1498.

Full text

Abstract:

Thesis (Master Diploma(Medical Technology) -- Cape Technikon, Cape Town, 1990<br>Eighty six patients with acute l.eukaemia were studied using morphol.ogical., cytochemical. and immunol.ogical. techniques. The acute l.eukaemias were subdivided using the French-American-British (FAB) cl.assification. The immunophenotyping studies were compared with the morphological classification to assess their contribution to the diagnosis. Acute non-lymphoblastic leukaemia (ANLL) was diagnosed on the basis of morphol.ogy and cytochemical. criteria. In addition this group of patients was studied with

APA, Harvard, Vancouver, ISO, and other styles

28

Wang, Qiao. "Analysis of the role of invariant V[alpha]24+NKT cells in the pathogenesis of chronic lymphocytic leukaemia /." [St. Lucia, Qld.], 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16185.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Willander, Kerstin. "Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers." Doctoral thesis, Linköpings universitet, Avdelningen för cellbiologi, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-104951.

Full text

Abstract:

The present thesis is focused on the prognostic value of genetic variations and alterations in the initiation and development of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) patients. Several prognostic markers based on genetic or chromosomal aberrations are today used in clinic in these heterogeneous diseases. Novel biomarkers have been identified through next generation sequencing techniques and some of them may be useful as prognostic markers in clinical diagnostic. In papers I-IV we have investigated some of this markers in CLL and AML tumor cells. In papers I and II

APA, Harvard, Vancouver, ISO, and other styles

30

Shalapour, Shabnam [Verfasser]. "Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia / Shabnam Shalapour." Berlin : Freie Universität Berlin, 2010. http://d-nb.info/1024054853/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Thompson, Bridget. "Murine acute myeloid leukemia cells expressing the cytosine deaminase gene induce protective immunity to parental leukemic cells." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape4/PQDD_0020/MQ54149.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Mandal, Tamoghna [Verfasser]. "Targeting leukemic stem cells in a murine model of CALM-AF10 positive acute myeloid leukemia / Tamoghna Mandal." Ulm : Universität Ulm, 2021. http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-38981-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Geletu, Heye Mulu. "Proteomic analysis of acute promyelocytic leukemia." Diss., lmu, 2006. http://nbn-resolving.de/urn:nbn:de:bvb:19-63200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Wallin, Michael. "Fusion activation in murine leukemia virus /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-748-0/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Brain-Holcomb, Julia M. "Genomic instability in chronic myelogenous leukemia." Thesis, McGill University, 2001. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=37874.

Full text

Abstract:

Chronic myelogenous leukemia (CML) is a disease arising from a reciprocal translocation between chromosome 9 and 22. Chromosome 22 encodes the Bcr gene, while chromosome 9 gives rise to the proto-oncogene, c-abl. In CML, these two genes form a fusion protein known as Bcr/Abl, which contains a constitutively activated protein tyrosine kinase. The focus of my research has been to address genomic instability as it relates to CML.<br>Initially, I addressed genomic instability by utilizing Inter Simple Sequence Repeat Polymerase Chain Reaction (Inter-SSR PCR), in combination with primers which cons

APA, Harvard, Vancouver, ISO, and other styles

36

Matthews, Christine. "Molecular genetics of chronic lymphocytic leukemia." Thesis, University of Ulster, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Baliakas, Panagiotis. "Reappraising prognosis in chronic lymphocytic leukemia." Doctoral thesis, Uppsala universitet, Institutionen för immunologi, genetik och patologi, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-280943.

Full text

Abstract:

Chronic lymphocytic leukemia (CLL) exhibits remarkable clinical heterogeneity likely reflecting the underlying biological heterogeneity. The genetic landscape of CLL has been recently enriched with mutations within a number of genes proposed as novel prognostic markers. Mounting evidence also supports the pivotal role of the clonotypic B-cell receptor immunoglobulin (BcR IG) in the natural history of CLL. Interestingly, almost 30% of all CLL patients can be assigned to different patient subsets, each defined by expression of a distinct stereotyped BcR IG. Whether stereotyped subsets exhibit di

APA, Harvard, Vancouver, ISO, and other styles

38

Yalyzhko, M., Наталія Олександрівна Симоненко, Наталия Александровна Симоненко, and Nataliia Oleksandrivna Symonenko. "Epidemiological features of leukemia in children." Thesis, Sumy State University, 2020. https://essuir.sumdu.edu.ua/handle/123456789/78017.

Full text

Abstract:

The problem of childhood leukemia is being discussed in the papers of the researchers from all parts of the world. This pathology is almost 1/3 of all malignancies in children and ranks first among the diseases of blood. The most common type of acute leukemia in children is acute lymphoblastic leukemia accounting for 80% of all the cases. The incidence of leukemia ranges from 3.2 to 4.4 per 100 thousand children under the age of 15 years. Peak incidence occurs at age of 2-5 years. 50% of childhood cancer deaths occur because of leukemia. Nowadays an extensive research work is being carried on

APA, Harvard, Vancouver, ISO, and other styles

39

Лобода, Андрій Миколайович, Андрей Николаевич Лобода, and Andrii Mykolaiovych Loboda. "Liposomal Nanoparticles for Pediatric Leukemia Therapy." Thesis, University of Latvia, 2019. http://essuir.sumdu.edu.ua/handle/123456789/73975.

Full text

Abstract:

Селективна доставка протиракових агентів до ракових клітин без шкоди для здорових клітин є основною метою нової терапії лейкемії у дітей на основі наночасток. Низка досліджень показують, що рецептори ліпопротеїдів (особливо рецептор до ліпопротеїдів високої щільності) дуже активні на поверхні злоякісних лейкозних клітин, тому можуть використовуватися в якості каналів для доставки протиракових агентів. Ліпосомальний сульфат вінкристину був першою наноформацією, що отримала схвалення FDA для лікування Ph+ гострої лімфобластної лейкемії у дорослих. Діти переносять тижневу дозу 2,25 мг/м2 ліпосома

APA, Harvard, Vancouver, ISO, and other styles

40

VARINELLI, MARCO. "MODELLING CHRONIC MYELOID LEUKEMIA IN ZEBRAFISH." Doctoral thesis, Università degli studi di Brescia, 2021. http://hdl.handle.net/11379/544088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Järviaho, T. (Tekla). "Germline predisposition to childhood acute lymphoblastic leukemia and bone marrow failure, and mitochondrial DNA variants in leukemia." Doctoral thesis, Oulun yliopisto, 2018. http://urn.fi/urn:isbn:9789526220437.

Full text

Abstract:

Abstract Childhood acute lymphoblastic leukemia (ALL) is the most common cancer in children. The overall survival rate has reached to 90%. However, ALL still presents a significant disease burden and is a major cause for deaths in children. Recently, both inherited germline variants related to ALL susceptibility and somatic genetic variants forming novel subgroups of ALL have been discovered. In this thesis two families with familial ALL were studied. Constitutional heterozygous microdeletion at chromosome 7p12.1p13, including IKZF1, was discovered in the first family with intellectual impairm

APA, Harvard, Vancouver, ISO, and other styles

42

APRILE, LARA. "Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application." Doctoral thesis, Università di Siena, 2017. http://hdl.handle.net/11365/1010532.

Full text

Abstract:

Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder characterized by the presence of the BCR-ABL1 oncogene, deriving from the t(9;22)-(q34;q11) balanced translocation. The deriving BCR-ABL1 fusion protein has tyrosine kinase activity, and it is capable of inducing the proliferation and expansion of myeloid precursors. Tyrosine kinase inhibitors, drugs capable of blocking the malignant proliferation of cells by directly targeting the BCR-ABL1 kinase activity, have dramatically changed patients’s outcome and improved survival rate. Dormant CML-Leukemia Stem Cells (LSCs) are intrinsi

APA, Harvard, Vancouver, ISO, and other styles

43

卓大治 and Tai-chi Cheuk. "Childhood acute lymphoblastic leukaemia with TEL-AML1 gene fusion." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31969690.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Cheuk, Tai-chi. "Childhood acute lymphoblastic leukaemia with TEL-AML1 gene fusion." Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B22264619.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Flores, Violante Mario. "Role of the Bone Morphogenetic Proteins pathway in leukemic stem cell regulation and resistance in acute myeloid leukemia." Thesis, Lyon, 2019. http://www.theses.fr/2019LYSE1118/document.

Full text

Abstract:

Les leucémies aiguës myéloïdes (LAM) sont des maladies hématologiques hétérogènes caractérisées par une prolifération clonale des blastes myéloïdes qui s’infiltrent dans la moelle osseuse (MO), le sang et d’autres organes. Identifiée comme le type le plus courant de leucémie aiguë chez l’adulte avec 80% des cas, la LAM est synonyme de rechute et de mauvais pronostic, avec 70% des patients étant confrontés à une mortalité dans l’année suivant le diagnostic. La présence des cellules souches leucémiques (CSL) a été associée à une résistance à la chimiothérapie et à une rechute dans la LAM. Le mic

APA, Harvard, Vancouver, ISO, and other styles

46

蘇志偉 and Chi-wai So. "Studies on the mixed lineage leukemia gene and identification of a novel partner gene, EEN, in human leukemia." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1996. http://hub.hku.hk/bib/B31236145.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Giacopelli, Brian John. "Global DNA methylation analysis of chronic lymphocytic leukemia and acute myeloid leukemia reveals distinct clinically relevant biological subtypes." The Ohio State University, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1591114255694166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

So, Chi-wai. "Studies on the mixed lineage leukemia gene and identification of a novel partner gene, EEN, in human leukemia /." Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B18156885.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

García, Montolío Marc 1991. "The Role of PHF19 in myeloid leukemia." Doctoral thesis, Universitat Pompeu Fabra, 2019. http://hdl.handle.net/10803/667911.

Full text

Abstract:

Polycomb group (PcG) of proteins are a group of highly conserved epigenetic regulators involved in many biological functions such as embryonic development, stem cell self-renewal, cell proliferation, and cancer. PHD finger protein 19 (PHF19) is an associated factor of Polycomb Repressor Complex 2 (PRC2) that has been proposed to regulated its activity in embryonic stem cells. PHF19 has been shown to be up-regulated in different human cancers as well as cancer cell lines. In particular, myeloid leukemia cell lines show increased levels of PHF19, yet little is known about its function. Here, we

APA, Harvard, Vancouver, ISO, and other styles

50

Palle, Josefine. "Optimizing Chemotherapy in Childhood Acute Myeloid Leukemia." Doctoral thesis, Uppsala University, Department of Women's and Children's Health, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9189.

Full text

Abstract:

<p>Despite major advances in our understanding of the biology of childhood acute myeloid leukemia (AML) and the development of new cytotoxic drugs, the prognosis of long-term survival is still only 60-65 %.</p><p>In the present research, we studied the pharmacokinetics of drugs used in the induction therapy of childhood AML and performed in vitro drug sensitivity testing of leukemic cells from children with AML.</p><p>The aims of the studies were to correlate the results of the analysis to biological and clinical parameters and to identify subgroups of AML with specific drug sensitivity profil

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!